This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Products


Aldurazyme® (laronidase)
Aldurazyme®

MAT-XU-2200954 (v6.0) Date of Preparation: April 2024  

AVAXIM® (hepatitis A vaccine (inactivated, adsorbed))
Avaxim®

MAT-XU-2301117 (v2.0) Date of preparation: October 2023  

Avaxim® Junior (hepatitis A vaccine (inactivated, adsorbed))
Avaxim® Junior

MAT-XU-2301296 (v3.0) Date of preparation: October 2023  

Cerdelga®▼ (hard capsules eliglustat)
Cerdelga®

MAT-XU-2204064 (v3.0) Date of preparation: October 2023  

Cerezyme® (imiglucerase for injection)
Cerezyme®

MAT-XU-2204065 (v3.0) Date of preparation: October 2023  

Clexane (enoxaparin)
Clexane®

MAT-XU-2204397 (v4.0) Date of Preparation: October 2023  

Fabrazyme® (agalsidase beta)
Fabrazyme®

MAT-GB-2105812 (v6.0) Date of preparation: March 2024  

Lantus® (insulin glargine 100 units/mL)
Lantus®

MAT-XU-2201444 (v4.0) Date of Preparation: October 2023  

Lemtrada® (alemtuzumab)
Lemtrada®

MAT-XU-2200680 (v3.0) Date of Preparation: December 2023  

GB only content
MenQuadfiTM▼  (meningococcal (group A,C,W,Y) conjugate vaccine)
MenQuadfiTM▼ 

MAT-XU-2400154 (v2.0) Date of preparation: April 2024  

Myozyme® (alglucosidase alfa)
Myozyme®

MAT-XU-2302935 (v1.0) Date of preparation: October 2023  

GB only content
Nexviadyme Logo
Nexviadyme®

MAT-XU-2203480 (v10.0) Date of preparation: March 2024  

Praluent® (alirocumab)
Praluent®

MAT-XU-2204604 (v4.0) Date of Preparation: October 2023  

Quadrivalent Influenza Vaccine (split virion, inactivated)
Quadrivalent Influenza Vaccine

MAT-XU-2301127 (v2.0) Date of preparation: October 2023  

Quadrivalent Influenza Vaccine▼

MAT-XU-2402066 (v1.0) Date of preparation: June 2024  

Repevax® (diphtheria, tetanus, pertussis and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
Repevax®

MAT-XU-2301125 (v3.0) Date of preparation: October 2023  

Revaxis® diphtheria, tetanus & poliomyelitis (inactivated) vaccine (absorbed, reduced antigen(s) content)
Revaxis® 

MAT-XU-2301123 (v2.0) Date of preparation: October 2023  

GB only content
Sarclisa Logo
SARCLISA®

MAT-XU-2202578 (v3.0) Date of preparation: December 2023  

Stamaril® (yellow fever vaccine (live))
Stamaril®

MAT-XU-2301130 (v2.0) Date of preparation: October 2023  

GB only content
Supemtek▼ (quadrivalent Influenza Vaccine (recombinant, prepared in cell culture))
Supemtek▼

MAT-XU-2301126 (v2.0) Date of preparation: December 2023  

Toujeo® (insulin glargine 300 units/ml)
Toujeo®

MAT-XU-2302426 (v11.0) Date of Preparation: April 2024  

Typhim Vi® (typhoid polysaccharide vaccine)
Typhim Vi®

MAT-XU-2301128 (v2.0) Date of preparation: October 2023  

GB only content
Vaxelis®

MAT-XU-2301124 (v4.0) Date of preparation: April 2024  

Viatim®

MAT-XU-2305576(v1.0) Date of preparation: December 2023  

MAT-XU-2305047 (v1.0) - Date of preparation: November 2023